The first personalized AI-targeted tumor vaccine production line in our country is under construction in Beijing Economic-Technological Development Area.

According to the news from "Beijing Yizhuang", recently, Beijing Likang Life Science and Technology Co., Ltd. drug research and production center project officially started construction in Beijing Economic and Technological Development Zone. The total investment of the project is about 110 million yuan, which will build a research and development laboratory and China's first AI+ personalized target tumor vaccine production line. It is expected to be completed and put into operation in October 2026.